SABBY 13G GALE 2.15.17

Company

SELLAS Life Sciences Group, Inc.

Filed

February 15, 2017

Accession Number

0001535610-17-000071

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →